g-finder.

Global investments into neglected disease R&D

G-FINDER logo

The G-FINDER project tracks and reports on global investments into research and development (R&D) for neglected diseases.

G-FINDER is a uniquely informative data source, providing policy-makers, donors, researchers and industry with an understanding of the landscape for neglected disease R&D, where funding gaps exist, and how their investments fit into the global picture:

  • in 33 neglected diseases;
  • across 142 product areas for these diseases including drugs, vaccines, diagnostics, microbicides and vector control products; and
  • in platform technologies (e.g. adjuvants, delivery technologies, diagnostic platforms)

The data includes all types of product-related R&D, including basic research, discovery and pre-clinical, clinical development, Phase IV and pharmacovigilance studies, and baseline epidemiological studies.

Funded by the Bill & Melinda Gates Foundation since inception, the G-FINDER project was originally hosted at The George Institute for International Health and then run by Policy Cures from 2010. Following the establishment of Policy Cures Research (PCR) as a separate organisations in 2016, the G-FINDER project is conducted by Policy Cures Research.

 


G-FINDER database (public search tool)

The G-FINDER Public Search Tool provides access to G-FINDER survey data. The Public Search Tool is updated annually and search results can be exported into Microsoft Excel for flexible data analysis.

Image of public search tool and Policy Cures Research

 


Policy Cures Research G-FINDER Reports

G-FINDER 2017 Neglected Disease Research and Development: Reflecting on a decade of global investment

To be launched Wednesday 13 December in London


G-FINDER 2016 Neglected Disease Research and Development: A Pivotal Moment in Global Health

The ninth G-FINDER report was launched on 16 February 2017, in Brussels, Belgium


Reference materials


Reports from our previous organisation

For older G-FINDER reports and associated publications produced prior to the separation of Policy Cures Research and Policy Cures into two organisations, please see: www.policycures.org/g-finder.html